NL6912502A - - Google Patents

Info

Publication number
NL6912502A
NL6912502A NL6912502A NL6912502A NL6912502A NL 6912502 A NL6912502 A NL 6912502A NL 6912502 A NL6912502 A NL 6912502A NL 6912502 A NL6912502 A NL 6912502A NL 6912502 A NL6912502 A NL 6912502A
Authority
NL
Netherlands
Application number
NL6912502A
Other versions
NL161669C (nl
NL161669B (nl
Inventor
Jr J A Miller
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NL6912502A publication Critical patent/NL6912502A/xx
Publication of NL161669B publication Critical patent/NL161669B/xx
Application granted granted Critical
Publication of NL161669C publication Critical patent/NL161669C/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL6912502.A 1968-08-15 1969-08-15 Werkwijze ter bereiding van een farmaceutisch preparaat met pijnstillende werking, dat een fenoxyfenylalkaan- carbonzuur bevat, en gevormd farmaceutisch preparaat. NL161669C (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75278768A 1968-08-15 1968-08-15
US75278868A 1968-08-15 1968-08-15

Publications (3)

Publication Number Publication Date
NL6912502A true NL6912502A (enExample) 1970-02-17
NL161669B NL161669B (nl) 1979-10-15
NL161669C NL161669C (nl) 1980-03-17

Family

ID=27115647

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6912502.A NL161669C (nl) 1968-08-15 1969-08-15 Werkwijze ter bereiding van een farmaceutisch preparaat met pijnstillende werking, dat een fenoxyfenylalkaan- carbonzuur bevat, en gevormd farmaceutisch preparaat.

Country Status (12)

Country Link
BE (1) BE737415A (enExample)
CA (1) CA974451A (enExample)
CY (1) CY782A (enExample)
DE (1) DE1941583C3 (enExample)
FR (1) FR2015729B1 (enExample)
GB (1) GB1250582A (enExample)
IE (1) IE33502B1 (enExample)
IL (1) IL32781A (enExample)
LU (1) LU59283A1 (enExample)
MY (1) MY7500035A (enExample)
NL (1) NL161669C (enExample)
SE (1) SE374269B (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU528532B2 (en) * 1978-12-18 1983-05-05 Mcniel Laboratories Acetaminophen analgesic potentiation
EP0068838B1 (en) * 1981-06-26 1986-09-17 The Upjohn Company Analgesic process and composition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU38115A1 (enExample) * 1959-01-07

Also Published As

Publication number Publication date
CA974451A (en) 1975-09-16
SE374269B (enExample) 1975-03-03
FR2015729A1 (enExample) 1970-04-30
NL161669C (nl) 1980-03-17
DE1941583C3 (de) 1980-06-04
DE1941583A1 (de) 1970-07-09
LU59283A1 (enExample) 1970-02-13
IL32781A0 (en) 1969-12-31
MY7500035A (en) 1975-12-31
DE1941583B2 (de) 1979-08-23
NL161669B (nl) 1979-10-15
BE737415A (enExample) 1970-02-13
CY782A (en) 1975-03-01
FR2015729B1 (enExample) 1974-02-01
GB1250582A (enExample) 1971-10-20
IE33502B1 (en) 1974-07-24
IL32781A (en) 1974-01-14
IE33502L (en) 1970-02-15

Similar Documents

Publication Publication Date Title
AU5506869A (enExample)
AU2374870A (enExample)
AU5184069A (enExample)
AU6168869A (enExample)
AU6171569A (enExample)
AU416157B2 (enExample)
AU429879B2 (enExample)
FR2015729B1 (enExample)
AU2581067A (enExample)
AU4811568A (enExample)
AU421558B1 (enExample)
AU2580267A (enExample)
AU3224368A (enExample)
AR203075Q (enExample)
AU4744468A (enExample)
AU479393A (enExample)
AU463027A (enExample)
BE581157A (enExample)
BE717976A (enExample)
AU2889368A (enExample)
AU2496167A (enExample)
BE712805A (enExample)
AU4503667A (enExample)
BE708888A (enExample)
BE727607A (enExample)

Legal Events

Date Code Title Description
V1 Lapsed because of non-payment of the annual fee
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: LILLY